Dipartimento Farmacia e Biotecnologie (FABIT), Università di Bologna, Via Selmi 3, 40126 Bologna, Italy.
Dipartimento Farmacia e Biotecnologie (FABIT), Università di Bologna, Via Selmi 3, 40126 Bologna, Italy.
Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):582-590. doi: 10.1016/j.bbabio.2017.02.006. Epub 2017 Feb 14.
Energy homeostasis is pivotal for cell fate since metabolic regulation, cell proliferation and death are strongly dependent on the balance between catabolic and anabolic pathways. In particular, metabolic and energetic changes have been observed in cancer cells even before the discovery of oncogenes and tumor suppressors, but have been neglected for a long time. Instead, during the past 20years a renaissance of the study of tumor metabolism has led to a revised and more accurate sight of the metabolic landscape of cancer cells. In this scenario, genetic, biochemical and clinical evidences place mitochondria as key actors in cancer metabolic restructuring, not only because there are energy and biosynthetic intermediates manufacturers, but also because occurrence of mutations in metabolic enzymes encoded by both nuclear and mitochondrial DNA has been associated to different types of cancer. Here we provide an overview of the possible mechanisms modulating mitochondrial energy production and homeostasis in the intriguing scenario of neoplastic cells, focusing on the double-edged role of 5'-AMP activated protein kinase in cancer metabolism. This article is part of a Special Issue entitled Mitochondria in Cancer, edited by Giuseppe Gasparre, Rodrigue Rossignol and Pierre Sonveaux.
能量平衡对于细胞命运至关重要,因为代谢调节、细胞增殖和死亡强烈依赖于分解代谢和合成代谢途径之间的平衡。特别是,在发现癌基因和肿瘤抑制基因之前,就已经观察到癌细胞的代谢和能量变化,但长期以来一直被忽视。相反,在过去的 20 年中,肿瘤代谢研究的复兴导致了对癌细胞代谢景观的修正和更准确的认识。在这种情况下,遗传、生化和临床证据将线粒体作为癌症代谢重构的关键因素,不仅因为它们是能量和生物合成中间产物的制造商,还因为核 DNA 和线粒体 DNA 编码的代谢酶的突变与不同类型的癌症有关。在这里,我们概述了调节线粒体能量产生和动态平衡的可能机制,在肿瘤细胞这一引人入胜的情景中,重点关注 5'-AMP 激活蛋白激酶在癌症代谢中的双刃剑作用。本文是由 Giuseppe Gasparre、Rodrigue Rossignol 和 Pierre Sonveaux 编辑的题为“癌症中的线粒体”的特刊的一部分。